CVS Health said drugmaker 340B contract pharmacy restrictions contributed to a decline in the company's pharmacy services revenue.

CVS Cites 340B Contract Pharmacy Restrictions in 19% Income Drop in Its Pharmacy Services

CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at